CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer-Reference-Cited by-同舟云学术

CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer

Published:2020-03-04 Issue:4 Volume:53 Page:210-217
ISSN:0891-6934
Container-title:Autoimmunity
language:en
Short-container-title:Autoimmunity

Author:

Shi Shanping¹,Ye Shazhou¹,Mao Jianmei¹,Ru Yuqing¹,Lu Yicong¹,Wu Xiaoyue¹,Xu Mingjun¹,Zhu Tingwei¹,Wang Yibo¹,Chen Yuanming¹,Tang Xiaoli¹,Xi Yang¹

Affiliation:

1. Diabetes Center, Zhejiang Provincial Key Laboratory of Pathophysiology, Institute of Biochemistry and Molecular Biology, School of Medicine, Ningbo University, Ningbo, China

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08916934.2020.1735371

Reference37 articles.

1. Cancer de l’estomac métastatique : les essais cliniques en Asie et en Occident

2. The burden of stomach cancer in indigenous populations: a systematic review and global assessment

3. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

4. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

5. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of clear cell renal cell carcinoma prognosis based on an immunogenomic landscape analysis;Heliyon;2024-08

2. Exploring the Cause of Survival Disparities in EGFR-Mutated Lung Cancer Subtypes: Unraveling Distinctive Genomic and Phenotypic Features of 19Del and L858R Mutation Subtypes;Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry;2024-06

3. Use of Transcriptomics to Reveal the Joint Immunotoxicity Mechanism Initiated by Difenoconazole and Chlorothalonil in the Human Jurkat T-Cell Line;Foods;2023-12-21

4. Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers;European Journal of Pharmacology;2023-12

5. Exploring the Cause of Survival Disparities in EGFR-mutated Lung Cancer Subtypes: Unraveling Distinctive Genomic and Phenotypic Features of 19Del and L858R Mutation Subtypes;2023-09-12